Can Kymera Therapeutics’ (KYMR) Oral Degraders Redefine Its Long-Term Edge Over Biologic Rivals?

This Week's Market Wrap: Strait To Jail

Mercury Systems Acquisition Brings Critical Manufacturing In House For Defense Programs

15 stocks in the S&P 500 showing double-digit gains since the attack on Iran began

The war is not over even if the stock market wants it to be

6 Under-The-Radar S&P 500 Stocks Quietly Recommended By Analysts